Username or email address *
Lost your password?
Your Email (required)
Please prove you are human by selecting the Heart.
A comprehensive genomic risk assessment for hereditary central nervous system tumours is a state-of-the-art DNA analysis using the cutting-edge technology of next-generation DNA sequencing to find germline mutations that may increase your patient’s risk of developing central nervous system tumours.
This advanced genomic risk assessment test for hereditary central nervous system tumours is recommended if your patient has a strong family history of central nervous system tumours.
By knowing your patient’s genetic background and her/his potential risk for developing central nervous system tumours, your patient can make informed decisions regarding her/his lifestyle, which may dramatically reduce her/his risk of developing this type of malignancy.
If the results show that your patient is genetically predisposed to developing central nervous system tumours, her/his prognosis will be significantly improved by having regular health screenings at shorter intervals.
Up to 8 weeks.
The DNA sample can be taken from the patient in your clinic by using one saliva collection kit that can be posted back to Genomic Medicine UK using the provided Royal Mail prepaid envelope.
This profile is only available for Genomic Medicine UK partner medical doctors. The chargeable fee for this profile is currently £399. If you instruct us to charge your patient directly, the patient’s price will be £499.
If you would like to request this profile for one of your patients simply click on the ‘ORDER BY POST’ icon and follow the instructions. Alternatively, you can use our electronic request form or the paper-based request form.